Alterity Therapeutics Limited Share Price Nasdaq
Equities
ATHE
US02155X2053
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.05 USD | -4.21% | -18.33% | -17.67% |
04-29 | Alterity Therapeutics Limited Presents New Data Demonstrating Potential of ATH434 to Treat Rare Neurodegenerative Diseases | CI |
04-16 | ADRs End Lower, Purple Biotech Ltd. Declines 29% | DJ |
Sales 2024 * | 1.87M 149M | Sales 2025 * | 1.39M 111M | Capitalization | 17.34M 1.38B |
---|---|---|---|---|---|
Net income 2024 * | -8M -638M | Net income 2025 * | -10M -797M | EV / Sales 2024 * | 9.29 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 12.5 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 86.93% |
Latest transcript on Alterity Therapeutics Limited
1 day | -4.21% | ||
1 week | -18.33% | ||
Current month | -2.15% | ||
1 month | +11.72% | ||
3 months | -1.44% | ||
6 months | -14.58% | ||
Current year | -17.67% |
Managers | Title | Age | Since |
---|---|---|---|
David Stamler
CEO | Chief Executive Officer | 63 | 30/04/17 |
Geoffrey Kempler
FOU | Founder | 69 | 10/11/97 |
Phillip Hains
DFI | Director of Finance/CFO | 64 | 30/04/14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Geoffrey Kempler
FOU | Founder | 69 | 10/11/97 |
Peter Marks
BRD | Director/Board Member | 68 | 28/07/05 |
Lawrence Gozlan
BRD | Director/Board Member | 45 | 07/08/11 |
Date | Price | Change | Volume |
---|---|---|---|
03/05/24 | 2.05 | -4.21% | 14,680 |
02/05/24 | 2.14 | -2.73% | 41,203 |
01/05/24 | 2.2 | +5.01% | 52,904 |
30/04/24 | 2.095 | -4.56% | 69,366 |
29/04/24 | 2.195 | -12.55% | 170,887 |
Delayed Quote Nasdaq, May 03, 2024 at 09:30 pm
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+25.69% | 47.9B | |
+46.90% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- ATH Stock
- ATHE Stock